ArticleCell death & disease2024

APR-246 as a radiosensitization strategy for mutant p53 cancers treated with alpha-particles-based radiotherapy.

Or Michaeli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.